Covishield is a vaccine developed by the University of Oxford and AstraZeneca for the prevention of COVID-19. It is based on the ChAdOx1 nCoV-19 vaccine, which uses a genetically modified version of the common cold (adenovirus) that causes infections in chimpanzees to deliver the genetic material for the SARS-CoV-2 virus (the virus that causes COVID-19) to human cells.
PDF Name: Covishield Vaccine Details
No. of Pages:02
Download PDF Now: Click Here